Status:
UNKNOWN
Written Exposure Therapy for Post-traumatic Stress Syndrome
Lead Sponsor:
Karolinska Institutet
Conditions:
Post Traumatic Stress Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To investigate if written exposure therapy is feasible for patients with post-traumatic stress disorder
Detailed Description
A non-inferiority trial in JAMA Psychiatry showed that written exposure therapy (WET) was non-inferior to a gold standard CBT treatment. In comparison to other trauma-focused CBT protocols, WET genera...
Eligibility Criteria
Inclusion
- Meet criteria for PTSD.
- If taking psychotropic medication, then the dose must be stable for at least 4 weeks prior to study entry.
- ≥ 18 years
- Situated in Sweden
- Be able to express themselves in Swedish, both in verbally and written form.
- Informed consent
Exclusion
- Other serious comorbidity as primary concern (ongoing substance dependence, untreated bipolar disorder, psychotic symptoms, severe depression, borderline personality disorder, high suicidal risk according to the MINI)
- Ongoing CBT for trauma
- Ongoing trauma-related threat (e.g. living with a violent spouse)
Key Trial Info
Start Date :
October 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 27 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04328935
Start Date
October 27 2020
End Date
April 27 2022
Last Update
June 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Sweden